Iradimed (IRMD) Notes Payables (2013)
Iradimed (IRMD) posted quarterly Notes Payables of $6333.0 for Q4 2013.
Iradimed (IRMD) Notes Payables (2013) Analysis & Trends
Iradimed has reported Notes Payables for 1 years, with the latest figure at $6333.0 in Q4 2013.
- Notes Payables for Q4 2013 came in at $6333.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2013 was $6333.0 (changed N/A YoY), and the FY2013 annual result was $6333.0, changed N/A from the prior year.
- Notes Payables steadied at $6333.0 in Q4 2013.
- Over five years, Notes Payables peaked at $6333.0 in Q4 2013 and troughed at $6333.0 in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn |
| 10 | Iradimed | 1.11 Bn | 1.05 Bn | 15.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 6,333.00 |